synthetic peptide; a nasal solution used in the treatment of AIDS-related Kaposi sarcoma
Also Known As:
IM 862 dipeptide; L-Glu-L-Trp; L-glutamyl-L-tryptophan; Thymogen
Networked: 36 relevant articles (6 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Petlenko, S V: 1 article (01/2011)
2. El'tsin, S S: 1 article (01/2011)
3. Smirnov, V S: 1 article (01/2011)
4. Toth, Istvan: 1 article (11/2007)
5. Bergeon, Julie A: 1 article (11/2007)
6. Autenshlius, A I: 1 article (01/2004)
7. Shkunov, A N: 1 article (01/2004)
8. Kuznetsova, N B: 1 article (01/2004)
9. Sedova, Iu V: 1 article (01/2004)
10. Rakhmanov, K G: 1 article (01/2004)

Related Diseases

1. Infection
05/01/1995 - "[The efficacy of using thymogen in an experimental infection caused by Yersinia enterocolitica]."
02/01/1993 - "[The clinico-epidemiological efficacy of thymogen in acute respiratory viral infections in a military collective]."
05/01/1995 - "The evaluation of the characteristics of cell reactions in the lymphoid organs of the immune system (the thymus, the spleen, lymph nodes), nonspecific resistance and specific humoral response showed the effectiveness of using thymogen: this preparation produced an immunoregulatory effect in the infected animals; it decreased their polyclonal immune response, the development of autoimmune reactions and promoted the intensive development of delayed hypersensitivity (DH) after their enteral infection with Y.enterocolitica O9 and had no effect on the development of DH in the animals infected with Y.enterocolitica O3; it also enhanced the nonspecific resistance of the body, thus leading to a decrease in the dissemination of the infective agents in different organs and tissues and to their subsequent elimination from the body."
01/01/1990 - "A reduction of the total antibiotic resistance of the agent in foci of skin infection and normalization of the immunologic reactivity parameters were recorded in 23 patients with chronic pyodermas after a course of thymogen therapy. "
01/01/1996 - "In progredient infection an early administration of reaferon in combination with thymogen is thought valid which in many patients is sufficient to prevent the disease transformation into a chronic form."
2. Pyoderma
3. Neoplasms (Cancer)
4. Tuberculosis (Tuberculoses)
5. Pancreatitis

Related Drugs and Biologics

1. Anti-Bacterial Agents (Antibiotics)
2. thymalin
3. Immunologic Factors (Immunomodulators)
4. Perforin
5. Pefloxacin
6. Streptomycin (Streptomycin Sulfate)
7. Rifampin (Rifampicin)
8. Levamisole (Decaris)
9. Isoniazid (Ftivazide)
10. Enzymes

Related Therapies and Procedures

1. Injections